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Abstract
Objective: Pulmonary emphysema is frequently associated with lung cancer and, because of the impaired pulmonary function involved,
it may contraindicate surgical treatment. However, improvement of pulmonary function has been observed after surgical resection in
patients with advanced emphysema. The aim of this study was to evaluate whether pulmonary emphysema, as assessed by pulmonary
function tests and radiological evaluation, can influence postoperative respiratory function after lobectomy for non-small cell lung cancer
(NSCLC). Methods: Respiratory function was evaluated before and after lobectomy for NSCLC. Radiological evaluation of emphysema
was performed on chest X-ray and CT scan. Patients that had undergone chemo- or radiotherapy or had segmental or lobar atelectasis were
excluded from the study. Results: Thirty-five patients entered the study. A decrease in static lung volumes was observed after surgery. Total
lung capacity (TLC) decreased from 6.58 – 0.92 to 5.46 – 0.77 l; functional residual capacity (FRC) from 3.70 – 0.88 to 2.96 – 0.73 l and
residual volume (RV) from 2.93 – 0.78 to 2.2 – 0.53 l. However, in a subgroup of 10 patients (Group 1), dynamic volumes after surgery
were unchanged or slightly increased (forced vital capacity (FVC) from 3.23 – 0.65 to 3.3 – 0.68 l; forced expiratory volume in 1 s (FEV1)
from 2.14 – 0.51 to 2.25 – 0.54 l), and airway resistances (sRaw) decreased from 15.58 – 5.18 to 11.42 – 5.25 cm H20/s. Preoperative data
showed that these patients had a greater obstruction, with FEV1 changing from 69 – 12.42 to 72.70 – 13.72% of predicted, as compared
with a change from 87 – 12.7 to 72.08 – 13.10% in the other group of 25 patients (Group 2). Correlation analysis reached statistical
significance between FEV1% variation (DFEV1%) and preoperative FEV1 and FVC% (r = - 0.49, P = 0.002 and r = - 0.5, P = 0.001,
respectively) and between D (FEV1)% and radiological scores for 3-level CT (r = 0.39, P = 0.04) and the sum of chest X-ray, single and 3-
level CT scores (r = 0.49, P = 0.01). Conclusions: Pulmonary function may remain unchanged or even increase after lobectomy in patients
with a pronounced emphysematous component of airway obstruction. The identification of preoperative parameters that identify this group
of patients could extend the indications for the treatment of lung cancer in patients with pulmonary emphysema. Ó 1999 Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Due to common risk factors such as smoke, pulmonary
emphysema may frequently coexist with lung cancer.
Although surgery still remains the main treatment for
early-stage non-small cell lung cancer (NSCLC) [1], the
impairment of respiratory function in patients with chronic
obstructive pulmonary disease (COPD) may contraindicate
surgical resection. Prediction of postoperative respiratory
function is therefore of paramount importance when asses-
sing indication to surgery in such patients. Parameters such
as predicted postoperative forced expiratory volume in 1 s
(ppoFEV1), carbon monoxide diffusing capacity (DLCO)
and oxygen consumption are usually used to assess oper-
ability [2].
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A reduction of about 15% of pulmonary function, as
evaluated by FEV1, is usually observed after lobectomy
[3]. The experience obtained in recent years with lung
volume reduction surgery (LVRS) has, nevertheless,
demonstrated that some improvement in pulmonary func-
tion may be observed after resection of pulmonary parench-
yma in patients with advanced emphysema, in some cases
by performing anatomical resections such as lobectomy [4].
A recent report by DeMeester et al. [5] has also demon-
strated that the improvement obtained with LVRS may
extend the indications for the resection of lung cancer to
patients with advanced emphysema. Whether a similar con-
cept could also be applied to lung cancer patients with a
lesser degree of emphysema is still unknown. Furthermore,
postoperative reduction of pulmonary function has actually
been found to be lower in patients with severe functional
impairment [3]. Other authors have even reported functional
improvement in selected cases after resection of pulmonary
parenchyma for the treatment of lung cancer [6,7]. The aim
of this study was to evaluate whether pulmonary emphy-
sema, as assessed by pulmonary function tests and radiolo-
gical evaluation, can influence postoperative respiratory
function after lobectomy for lung cancer.
2. Methods
From June 1997 to March 1998, 78 patients underwent a
lobectomy for early-stage NSCLC at the Department of
Thoracic Surgery of the Scientific Institute H San Raffaele,
University of Milan, Italy. Thirty-five patients entered the
study. The remaining patients were excluded from the study
because of preoperative atelectasis of a pulmonary segment
or a lobe, adjuvant chemo- or radiotherapy, poor perfor-
mance status and bullae larger than 3 cm. Preoperative
oncological assessment included total-body CT scan, bone
scan and bronchoscopy. Pulmonary function tests and ple-
tismography were performed in all 35 patients preopera-
tively and after a mean period of 4.7 (2–7) months after
surgery with V6200 Autobox equipment (Sensormedics,
Yorba Linda, CA). The measurements were recorded
according to the American Thoracic Society (ATS) criteria
[8]. The following parameters were assessed: flow/volume
loop (FEV1, forced vital capacity (FVC), FEV1/FVC, FEF
25–75%), static lung volumes (total lung capacity, TLC;
functional residual capacity, FRC; residual volume, RV).
Preoperative radiological documentation was available for
retrospective evaluation in 26 out of the 35 patients. Radi-
ological grading of emphysema was thus retrospectively
assessed in these patients by a radiologist (A.V.) who was
blinded to the results of the pulmonary function tests. The
radiological evaluation was performed on a lateral chest X-
ray and on CT scan obtained at full inspiration using the
grading system described by Slone and Gierada [9]. The
chest CT examination was included in the oncological eva-
luation and was obtained with a spiral CT scanner (Toshiba
X-press, Toshiba Medical Systems, Tokyo, Japan). The
thoracic region was scanned with 7 mm thick slices, a
table movement of 10 mm/s (Pitch 1.3) and contiguous
reconstructions (7 mm). Hyperinflation and flattening of
the diaphragm on the lateral chest X-ray was graded as: 0-
normal, 1-mild, 2-moderate, 3-marked, 4-severe. The grad-
ing of emphysema was evaluated on CT scan at the mid-
portion of the lobe to be resected and at three levels: the first
at the top of the aortic arch, the second 2 cm below the
carina and the third 2 cm above the diaphragm. The score
was rated as follows: grade 0, normal lung; grade 1 (mild),
more lung than airspace (,25%); grade 2 (moderate), even
distribution of airspace and lung (25–50%); grade 3
(marked), more airspace than normal lung (.50%); grade
4 (severe), no normal lung. The scores of the radiological
evaluation were used to make up the following indexes: A –
chest X-ray; B – (single-level CT) CT in the lobe to be
resected; C – (3 level CT score) sum of the CT scores
evaluated at three levels; D – (comprehensive radiology
score) sum of A, B and C.
3. Statistical analysis
Data are expressed as mean values – standard deviation.
Correlation between variables was assessed using Spearman
rank correlation coefficients. Comparison of radiological
scores between groups of patients were made using the
non-parametric Wilcoxon rank sum test. A P-value lower
than 0.05 was used as a threshold for statistical significance.
4. Results
Two patients were female and 33 male. The mean age
was 64 years (49–79). Twenty-five patients underwent an
upper lobectomy, seven a lower lobectomy and three a mid-
dle lobectomy. All the operations were performed through a
standard muscle-sparing lateral thoracotomy. Mean tumor
size was 3.3 cm (1–6). Postoperative pathological staging
was T1N0 in 12 patients, T2N0 in 12, T1N1 in three, T2N1
in three, T3N0 in one, T2N2 in three and T3N1 in one. A
decrease in static lung volumes was observed after surgery:
TLC decreased from 6.58 – 0.92 to 5.46 – 0.77 l; FRC
from 3.70 – 0.88 to 2.96 – 0.73 l and RV from 2.93 –
0.78 to 2.20 – 0.53 l. However, in a subgroup of 10 patients
(Group 1), dynamic volumes after surgery were unchanged
or slightly increased. In these patients, who had a higher
degree of airway obstruction, FVC increased from 3.23 –
0.65 to 3.30 – 0.68 l (80.33 – 8.29 to 83.20 – 13.11% of
predicted) while FEV1 increased from 2.14 – 0.51 to
2.25 – 0.54 l (69 – 12.42 to 72.70 – 13.72% of predicted);
airway resistances (sRaw) decreased from 15.58 – 5.18 to
11.42 – 5.25 cm H2O/s. In the remaining 25 patients (Group
2), FVC and FEV1 decreased respectively from 3.52 – 0.61
to 2.94 – 0.55 l (99 – 13.45 to 82.76 – 14.61% of pre-
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dicted) and from 2.47 – 0.48 to 2.03 – 0.43 l (87 – 12.7 to
72.08 – 13.10% of predicted); sRaw varied from 14.39 –
8.85 to 13.38 – 6.50 cm H2O/s. RV was higher in Group 1,
and changed from 3.27 – 0.87 to 2.23 – 0.69 l, as compared
with a decrease from 2.78 – 0.70 to 2.19 – 0.47 l after sur-
gery in Group 2 (Table 1). Correlation analysis between
changes in D(FEV1)% and preoperative FEV1 and FVC%
values reached statistical significance (r = - 0.49, P = 0.002
and r = - 0.5, P = 0.001, respectively). Radiological scores
assessed by chest X-ray and CT scan were higher in Group 1
than in Group 2 (Table 2), although these data did not reach
statistical significance. In all the patients with radiological
evidence of emphysema, a heterogeneous distribution was
observed. Correlation analysis also reached statistical sig-
nificance between changes in D(FEV1)% and radiological
scores for 3-level CT (r = 0.39, P = 0.04) and the sum of
chest X-ray, single and 3-level CT scores (r = 0.49,
P = 0.01) (Fig. 1). The last score also significantly corre-
lated with preoperative FEV1% (r = - 0.39, P = 0.04). This
was consistent with a higher degree of emphysema at chest
X-ray and CT scan in patients with higher airway obstruc-
tion.
5. Discussion
Despite the recent advances in radio- and chemotherapy
regimens, surgery remains the treatment of choice in early-
stage NSCLC. Since most lung cancer patients are smokers,
COPD frequently coexists and causes a limitation of pul-
monary function that may contraindicate surgery or require
the use of limited and therefore less radical resections [10].
A pulmonary resection usually involves a significant reduc-
tion of pulmonary function. In the early postoperative per-
iod, this is due to the surgical trauma to the lung and to the
chest wall, to the increase of bronchial secretions and to
postoperative pain, which may significantly impair post-
operative respiratory function. Despite advances in anesthe-
sia, surgical techniques and postoperative treatment with the
intensive use of chest physiotherapy, minitracheostomy and
epidural analgesia, further reduction in pulmonary function
exposes patients with an already limited respiratory function
to an increased risk of postoperative morbidity and mortal-
ity [11,12]. Three to six months after surgery, there is a
partial recovery of respiratory function although a reduction
in FEV1 of 9–17% and 31–36% of the preoperative values
is still observed after lobectomy and pneumonectomy,
respectively [13–15]. This may impair the quality of life
or even increase morbidity in patients who had a limited
pulmonary function preoperatively [16]. The prediction of
long-term postoperative function is therefore of great
importance when assessing operability.
Several functional factors have been studied as predictors
of outcome after pulmonary resection. Preoperative evalua-
tion usually includes tests such as spirometry, blood gas
analysis, DLCO and prediction of postoperative pulmonary
function, by means of split lung function perfusion scanning
and by calculating the contribution of the resected segments
to total lung function [17,18]. Specific tests are also used to
assess exercise capacity and to identify parameters that
seem to be associated with postoperative outcome, such as
maximum oxygen consumption and blood oxygen desatura-
tion [18–20].
Several functional criteria have been associated to opera-
tive risk. Gaensler [21] in 1955 identified a correlation
between spirometric values and outcome, and observed
that a maximal voluntary ventilation (MVV) lower than
50% of predicted was associated with an unfavorable out-
come. Olsen suggested that a ppoFEV1 under 800 ml was to
be considered a contraindication to surgical resection since
it could theoretically be associated with carbon dioxide
retention [22]. Ferguson [23] observed that predicted post-
operative DLCO% was an important predictor of postopera-
tive morbidity. Markos et al [18] noted that predicted
postoperative FEV1 (ppoFEV1), DLCO, predicted post-
operative DLCO (ppoDLCO), and oxygen desaturation dur-
ing exercise were predictive of postoperative pulmonary
complications. They recommended operability if ppoFEV1
was equal or higher than 40% of predicted and inoperability
if ppoFEV1 was lower than 30% [18]. Bechard and Wet-
Table 1
Summary of preoperative and postoperative pulmonary function tests
(PFTs) data
Group Preoperation Postoperation D%
FVC (l) 1 3.23 – 0.65 3.30 – 0.68 2.16
2 3.52 – 0.61 2.94 – 0.55 - 16.4
FEV1 (l) 1 2.14 – 0.51 2.25 – 0.54 5.14
2 2.47 – 0.48 2.03 – 0.43 - 17.8
TLC (l) 1 6.75 – 0.85 5.56 – 1.16 - 17.6
2 6.50 – 0.95 5.41 – 0.7 - 16.8
RV (l) 1 3.27 – 0.87 2.23 – 0.69 - 31.8
2 2.78 – 0.70 2.19 – 0.47 - 21.2
FRC (l) 1 4.04 – 1.24 3.05 – 0.84 - 24.5
2 3.54 – 0.63 2.92 – 0.69 - 17.5
Raw (cmH2O/s) 1 15.58 – 5.18 11.42 – 5.25 - 28.9
2 14.39 – 8.85 13.38 – 6.50 - 7.1
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; TLC,
total lung capacity; RV, residual volume; FRC, functional residual capa-
city; sRaw, specific airway resistance; D%, % change preoperative to post-
Table 2
Radiological visual assessment of emphysema
Score Group 1 Group 2 (P-value
in parenthesis)
A 1.63 – 1.41 0.78 – 1.07 (0.13)
B 1.13 – 1.13 0.61 – 0.78 (0.26)
C 3.00 – 2.45 1.67 – 1.94 (0.18)
D 5.75 – 4.27 3.06 – 3.32 (0.08)
Group 1, patients with stationary or improved postoperative function;
Group 2, patients with postoperative functional decrease. A, chest X-ray;
B, CT (resected lobe); C, 3 level CT; D, sum of A, B and C.
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stein [19] observed that patients with a maximal oxygen
consumption (MV02) lower than 10ml/kg per min had a
prohibitive surgical risk, while patients with an MV02
greater than 20 ml/kg per min had a low risk of postopera-
tive complications after pulmonary resection. Pierce et al.
[3] developed a predictive index of postoperative morbidity
by combining ppoFEV1% and ppoDLCO%. Melendez and
Barrera [24] modified this index by including (ppo
DLCO%)2 and A-a P02 and identifying a relationship
between these data and pulmonary complications, mortality
and hospital stay.
However, despite the sophisticated preoperative eval-
uation techniques currently available, Olsen [25] has
recently stressed the difficulty of establishing standard cri-
teria for the operability of lung cancer patients. This may be
particularly true for patients with emphysema. The devel-
opment of lung volume reduction surgery (LVRS) has in
fact raised new interest in the functional evaluation of
emphysema patients undergoing thoracic surgery. The pos-
sibility of improving lung function in patients with
advanced diffuse emphysema has been demonstrated after
LVRS [4]. The mechanisms of improvement seem to be
related to a restoration of the elastic recoil of pulmonary
parenchyma, which leads to a reduction in airway resistance
along with an improvement of diaphragmatic and respira-
tory mechanics [26]. The functional improvement that is ob-
tained with the resection of emphysematous parenchyma
may also allow the resection of viable parenchyma, as
reported by DeMeester et al. [5] in the treatment of asso-
ciated diseases.
Patients with a lesser degree of emphysema represent the
great majority of patients that undergo surgery for NSCLC.
The influence of the resection of lung parenchyma in this
group of patients still has to be thoroughly evaluated. In
particular, the correlation between emphysema and reduc-
tion of postoperative respiratory function could be impor-
tant in the selection of surgical candidates. Pierce et al. [3]
have in fact observed a relationship between the change in
FEV1 after surgery and the baseline predicted FEV1%,
therefore indicating that the functional loss is proportionally
less severe in patients with lower pulmonary function.
Accordingly, Larsen et al. [6] observed that patients with
a lower preoperative FVC had the smallest postoperative
deterioration in pulmonary function. In their series, patients
with a preoperative FEV1 of less than 74% (median) had a
lower postoperative reduction in FVC as compared with
patients with a FEV1 higher than 74%. Four patients with
a preoperative FEV1 of less than 50% actually improved
their postoperative FVC after the operation [6]. Recently,
Korst et al. [7] observed functional improvement after
lobectomy for NSCLC, in patients with a FEV1 of less
than 60% of predicted and a FEV1/FVC ratio of less than
0.6. They also developed a scoring system combining these
two parameters to identify preoperatively patients that could
have a limited reduction or even improvement of pulmonary
function [7].
The severity of emphysema can be evaluated not only by
means of pulmonary function tests, but also radiologically,
and a significant correlation has been demonstrated between
these two tests [27]. The radiological evaluation of emphy-
Fig. 1. Correlation between radiological emphysema score (X-ray + CT) and % change in FEV1.
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sema may therefore also be an important factor in the pre-
operative evaluation of candidates for surgical resection. A
significant correlation between functional improvement and
radiologic assessment has been demonstrated by Slone and
Gierada [9] in patients submitted to LVRS, and has been
confirmed by other authors [28,29].
In this study the degree of emphysema was assessed by
both pulmonary function tests and radiological evaluation.
A significant correlation was observed between the modifi-
cation of FEV1 measured preoperatively and after surgery,
preoperative respiratory function and preoperative radiolo-
gical grading of emphysema. Patients with a lower preo-
perative FEV1% had a smaller reduction in postoperative
function, and some cases actually improved their respiratory
function. The radiological index that best correlated with
the improvement in postoperative function combined the
evaluation of hyperinflation and diaphragmatic flattening,
as evaluated by lateral chest X-ray, and CT evaluation
both at the level of the resected lobe and at three levels.
This index had a higher correlation with the modification in
FEV1% than the severity of emphysema of the resected
lobe, therefore suggesting that the global degree of emphy-
sema together with the severity of emphysema of the
resected parenchyma may influence postoperative results.
Patients in Group 1, who had an unchanged or improved
function also had higher RV and TLC and had a significant
reduction in airway resistance as compared with patients in
Group 2, who had a worsened function after surgery. How-
ever, we were not able to identify a scoring system that
could combine radiological evaluation and preoperative
pulmonary function tests to identify preoperatively indivi-
dual patients who would improve their pulmonary function
after surgery. Further studies on a larger series of patients
are needed to achieve this aim.
In conclusion, patients with a more pronounced emphy-
sematous component of airway obstruction, as assessed by
pulmonary function tests and radiological evaluation, may
have unchanged or even increased pulmonary function after
lobectomy. The identification of preoperative parameters
capable of identifying this group of patients would enable
the indications for the treatment of lung cancer to be
extended in patients with pulmonary emphysema.
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Appendix A Conference discussion
Dr J. Hasse (Freiburg, Germany): What is the influence on the perio-
perative treatment, and the eventual stopping of smoking? Both could
interfere with your assumption that the resection itself was beneficial.
Dr Carretta: We didn’t evaluate the preoperative period in this study,
but, what we may say is that we have learned with lung volume reduction
surgery that it is possible to operate on patients with limited respiratory
function with acceptable morbidity. Also, that we could possibly apply
what we have learned with lung volume reduction surgery to other
patients, to other patients with a lesser degree of emphysema.
Dr W. Klepetko (Vienna, Austria): I think you very nicely pointed out
that there is a huge potential with emphysema surgery, even for patients
with bronchial carcinoma. However, I cannot follow your conclusions,
because I think that what you suggest is very dangerous.
Basically, if I correctly understood, you suggested that, the more sick
patients are, the more advanced emphysema they have, the better will be
the functional outcome after the lobectomy. I think emphysema is a very
different entity. You have homogenous forms and very heterogeneous
forms, and you should divide your patients in those groups. In addition,
patients, who have the tumor within the most destroyed area of lung will
benefit of course. But the other ones, who have not the tumor in the area of
destroyed parenchyma, they can experience a lot of harm by that operation.
So I wonder whether you have made any attempts on doing an anatomical
landmarking of the situation of the tumors, where they were situated, and
what was the grouping of the patients in terms of homogeneity and hetero-
geneity?
Dr Carretta: I certainly agree with you in saying that, of course, these
are preliminary results that only evaluate the pulmonary function after
recovery from the perioperative period, about 4 months after surgery.
We didn’t assess the exact perioperative complications in this group of
patients.
What is interesting to note, even if this is a limited group of patients, is
that we had a good correlation between improvement of respiratory func-
tion and radiological assessment with CT scan performed at the upper,
middle and lower pulmonary fields. The global degree of emphysema,
apart from the emphysema in the lobe to be resected, could also influence
these patients’ functional improvement.
Dr Klepetko: Could you precisely tell me how many of your patients
had the lesions within areas of resection, how many of them were in other
areas where you normally would not resect for an ordinary emphysema
surgery?
Dr Hasse: I think we should discuss that later. We have one very quick
question.
Dr S. Ambazidis (New South Wales, Australia): Have you considered
doing perfusion ventilation scans just as a way of defining the area you’re
going to resect?
Dr Carretta: No, we didn’t perform perfusion-ventilation scans in these
patients. We have started a new study to better assess the emphysema of
the area to be resected by combining ventilation perfusion scan, anatomi-
cal evaluation of emphysema and a stress test. However, we didn’t perform
this systematically in this group of patients, only in selected ones.
.
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